Innovative collection and use of health data will play a vital role in Europe’s future approach to medicines evaluation and regulation. This report explores what the EU can learn from Denmark, one of the world’s leaders in health data systems and strategies.
Sponsored by the Science|Business Future-Proofing Medicines initiative
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.